We are live on ! Find out more
CM

CM Management Portfolio holdings

AUM $157M Turnover 30.95%
1-Year Est. Return 60.08%
This Fund
S&P 500
This Quarter Est. Return
-3.12%
1 Year Est. Return
+60.08%
3 Year Est. Return
+110.48%
5 Year Est. Return
+186.03%
10 Year Est. Return
–
AUM
$112M
AUM Growth
-$13.3M
Cap. Flow
-$5.94M
Cap. Flow %
-5.31%
Top 10 Hldgs %
38.7%
Holding
66
New
2
Increased
18
Reduced
11
Closed
9
Avg Time Held
2.3 years
Top 10 Avg Time Held
1.8 years
Top 20 Avg Time Held
1.5 years

Top Buys

Rank Stock Value
1
HAS icon
Hasbro
HAS
+$1.31M
2
CPA icon
Copa Holdings
CPA
+$1.19M
3
FCX icon
Freeport-McMoran
FCX
+$895K
4
OGN icon
Organon & Co
OGN
+$815K
5
PAAS icon
Pan American Silver
PAAS
+$671K

Top Sells

Rank Stock Value
1
KD icon
Kyndryl
KD
+$3.22M
2
PFE icon
Pfizer
PFE
+$1.74M
3
HRI icon
Herc Holdings
HRI
+$1.28M
4
PRGO icon
Perrigo
PRGO
+$1.05M
5
WBD icon
Warner Bros
WBD
+$976K

Sector Composition

Rank Sector Weight
1 Healthcare 39.52%
2 Materials 10.9%
3 Industrials 10.07%
4 Technology 9.2%
5 Financials 8.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
ALCO icon
1
Alico
ALCO
$283M
$5.83M 5.21%
225,000
– –
2020 Q4
16 quarters
RLGT icon
2
Radiant Logistics
RLGT
$423M
$5.19M 4.64%
775,000
– –
2020 Q4
16 quarters
TGB
3
Trekor Metals
TGB
$3B
$4.75M 4.24%
2,450,000
– –
2020 Q4
16 quarters
CLPT icon
4
ClearPoint Neuro
CLPT
$282M
$4.46M 3.98%
290,000
-10,000
-3% -$130K
2021 Q4
12 quarters
FOLD icon
5
DELISTED
Amicus Therapeutics
FOLD
$4.24M 3.79%
450,000
– –
2020 Q4
16 quarters
RPRX icon
6
Royalty Pharma
RPRX
$26.3B
$4.08M 3.65%
160,000
– –
2023 Q4
4 quarters
RIGL icon
7
Rigel Pharmaceuticals
RIGL
$875M
$4.08M 3.64%
242,500
-47,500
-16% -$911K
2024 Q3
1 quarter
NMRK icon
8
Newmark Group
NMRK
$2.1B
$3.84M 3.43%
300,000
– –
2020 Q4
16 quarters
PLPC icon
9
Preformed Line Products
PLPC
$1.84B
$3.45M 3.08%
27,000
– –
2020 Q4
16 quarters
TALO icon
10
Talos Energy
TALO
$2.84B
$3.4M 3.04%
350,000
– –
2020 Q4
16 quarters
ARKO icon
11
ARKO Corp
ARKO
$453M
$3.24M 2.89%
1,050,000
+30,000
+3% +$207K
2021 Q1
15 quarters
INTT icon
12
inTEST
INTT
$168M
$3.14M 2.8%
365,000
+15,000
+4% +$114K
2023 Q4
4 quarters
CHRS icon
13
Coherus Oncology
CHRS
$162M
$2.83M 2.53%
2,050,000
+50,000
+3% +$56.1K
2020 Q4
16 quarters
PD icon
14
PagerDuty
PD
$1.31B
$2.74M 2.45%
150,000
– –
2023 Q2
6 quarters
CPA icon
15
Copa Holdings
CPA
$5.35B
$2.64M 2.35%
30,000
+12,500
+71% +$1.19M
2024 Q3
1 quarter
SABR icon
16
Sabre
SABR
$718M
$2.56M 2.28%
700,000
+50,000
+8% +$183K
2023 Q1
7 quarters
BGC icon
17
BGC Group
BGC
$5.37B
$2.49M 2.23%
275,000
– –
2020 Q4
16 quarters
VTRS icon
18
Viatris
VTRS
$20B
$2.49M 2.22%
200,000
– –
2020 Q4
16 quarters
RBCAA icon
19
Republic Bancorp
RBCAA
$1.78B
$2.45M 2.18%
35,000
– –
2020 Q4
16 quarters
OGN icon
20
Organon & Co
OGN
$3.61B
$2.24M 2%
150,000
+50,000
+50% +$815K
2023 Q2
6 quarters
IOVA icon
21
Iovance Biotherapeutics
IOVA
$6.44B
$2.22M 1.98%
300,000
+50,000
+20% +$463K
2023 Q3
5 quarters
ARKR icon
22
Ark Restaurants
ARKR
$16.2M
$2.2M 1.96%
200,000
– –
2020 Q4
16 quarters
BRKL icon
23
DELISTED
Brookline Bancorp
BRKL
$2.12M 1.9%
180,000
-45,000
-20% -$522K
2022 Q4
8 quarters
PK icon
24
Park Hotels & Resorts
PK
$3.05B
$2.11M 1.88%
150,000
– –
2023 Q1
7 quarters
CGAU icon
25
Centerra Gold
CGAU
$4.12B
$1.99M 1.78%
350,000
– –
2023 Q4
4 quarters
1
2 3

Similar funds

SFSG
Sound Financial Strategies Group Madison, Mississippi $157M AUM 15.51% 1-Year Est. Return
PTFIS
Pekao Towarzystwo Funduszy Inwestycyjnych SA Warsaw $157M AUM
AWMG
ADG Wealth Management Group Metairie, Louisiana $158M AUM 18.25% 1-Year Est. Return
LDNAM
Lepercq De Neuflize Asset Management New York $158M AUM 20.61% 1-Year Est. Return
DFS
Demming Financial Services Aurora, Ohio $157M AUM
APW
Aurora Private Wealth Rockaway, New Jersey $158M AUM
GA
Gagnon Advisors New York $157M AUM 36.77% 1-Year Est. Return
TC
Town Capital Bel Air, Maryland $158M AUM

CM Management's Q4 2024 Portfolio in Review

As of Q4 2024, CM Management held 66 positions worth $112M, down 11% from $125M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

CM Management withdrew a net $5.94M in Q4 2024, closing 9 positions and reducing 11 holdings. Its most notable exit was Kyndryl, an estimated $3.22M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 40% of assets, down from 40% a quarter earlier, followed by Materials and Industrials.

Against the trend, CM Management opened a new position in Hasbro worth $1.12M.

  • CM Management's largest Q4 2024 buy was Hasbro: 20,000 shares worth $1.12M.
  • CM Management added most to Copa Holdings in Q4 2024, an estimated $1.19M increase.
  • CM Management's biggest Q4 2024 reduction was Warner Bros, cutting an estimated $976K.
  • CM Management fully exited Kyndryl in Q4 2024, selling an estimated $3.22M.
  • CM Management's ten largest holdings make up 39% of its $112M portfolio in Q4 2024.
  • CM Management opened 2 new positions and closed 9 in Q4 2024.
  • CM Management's portfolio value fell 11% quarter-over-quarter to $112M.

Based on CM Management's 13F filing for Q4 2024, filed 7 Feb 2025.